Elizabeth Juarez-Colunga
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 6 | 2024 | 136 | 1.330 |
Why?
| | Models, Statistical | 5 | 2026 | 681 | 0.890 |
Why?
| | Vigabatrin | 2 | 2022 | 19 | 0.830 |
Why?
| | Arthroplasty, Replacement, Knee | 5 | 2025 | 370 | 0.710 |
Why?
| | Isoantibodies | 1 | 2021 | 57 | 0.670 |
Why?
| | Pseudomonas Infections | 2 | 2022 | 221 | 0.650 |
Why?
| | Graft Rejection | 2 | 2021 | 540 | 0.650 |
Why?
| | Cystic Fibrosis | 5 | 2025 | 1158 | 0.610 |
Why?
| | Machine Learning | 2 | 2021 | 585 | 0.570 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 69 | 0.560 |
Why?
| | Algorithms | 3 | 2025 | 1837 | 0.550 |
Why?
| | Vaccination Coverage | 1 | 2019 | 103 | 0.530 |
Why?
| | Behavior Therapy | 2 | 2019 | 299 | 0.490 |
Why?
| | Health Education | 1 | 2019 | 358 | 0.460 |
Why?
| | Longitudinal Studies | 6 | 2026 | 2947 | 0.460 |
Why?
| | Risk Assessment | 5 | 2019 | 3671 | 0.440 |
Why?
| | Papillomavirus Vaccines | 1 | 2019 | 297 | 0.440 |
Why?
| | Internet | 2 | 2020 | 699 | 0.440 |
Why?
| | Walking | 6 | 2026 | 545 | 0.430 |
Why?
| | Humans | 82 | 2026 | 144759 | 0.430 |
Why?
| | Papillomavirus Infections | 1 | 2019 | 345 | 0.430 |
Why?
| | Advance Care Planning | 4 | 2025 | 243 | 0.420 |
Why?
| | Epilepsies, Myoclonic | 3 | 2018 | 59 | 0.380 |
Why?
| | Data Mining | 1 | 2014 | 117 | 0.380 |
Why?
| | Amputees | 2 | 2026 | 98 | 0.380 |
Why?
| | Female | 57 | 2026 | 78271 | 0.370 |
Why?
| | Treatment Outcome | 9 | 2026 | 11679 | 0.370 |
Why?
| | Osteoarthritis, Knee | 3 | 2025 | 279 | 0.350 |
Why?
| | Renal Dialysis | 2 | 2026 | 462 | 0.350 |
Why?
| | Veterans | 7 | 2025 | 1603 | 0.340 |
Why?
| | Male | 50 | 2026 | 72315 | 0.340 |
Why?
| | Primary Health Care | 5 | 2026 | 1733 | 0.340 |
Why?
| | Epileptic Syndromes | 3 | 2021 | 95 | 0.330 |
Why?
| | Exercise Therapy | 3 | 2025 | 473 | 0.320 |
Why?
| | Family Planning Services | 2 | 2022 | 94 | 0.310 |
Why?
| | Postoperative Complications | 6 | 2018 | 2919 | 0.310 |
Why?
| | Recovery of Function | 5 | 2026 | 707 | 0.310 |
Why?
| | Aged | 28 | 2026 | 25913 | 0.310 |
Why?
| | Down Syndrome | 3 | 2021 | 534 | 0.300 |
Why?
| | Kidney Failure, Chronic | 2 | 2026 | 598 | 0.300 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1907 | 0.290 |
Why?
| | Tacrolimus | 2 | 2021 | 196 | 0.290 |
Why?
| | Contraception | 2 | 2022 | 169 | 0.290 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2925 | 0.290 |
Why?
| | Vision Disorders | 2 | 2021 | 178 | 0.280 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1053 | 0.280 |
Why?
| | Exercise | 3 | 2025 | 2201 | 0.280 |
Why?
| | Biomarkers | 4 | 2021 | 4271 | 0.280 |
Why?
| | Community Health Workers | 2 | 2026 | 87 | 0.270 |
Why?
| | Research Design | 1 | 2013 | 1135 | 0.260 |
Why?
| | Anticonvulsants | 2 | 2022 | 235 | 0.250 |
Why?
| | Patient Navigation | 2 | 2026 | 104 | 0.250 |
Why?
| | Child | 18 | 2025 | 22633 | 0.250 |
Why?
| | Middle Aged | 26 | 2026 | 35875 | 0.250 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 29 | 0.240 |
Why?
| | Arthroplasty, Replacement, Shoulder | 1 | 2026 | 40 | 0.230 |
Why?
| | Self-Management | 2 | 2025 | 201 | 0.230 |
Why?
| | Electroencephalography | 3 | 2024 | 532 | 0.230 |
Why?
| | Developmental Disabilities | 2 | 2019 | 281 | 0.230 |
Why?
| | Retrospective Studies | 18 | 2026 | 17066 | 0.220 |
Why?
| | Patient Portals | 1 | 2025 | 49 | 0.220 |
Why?
| | Markov Chains | 3 | 2026 | 129 | 0.220 |
Why?
| | Advance Directives | 1 | 2025 | 87 | 0.220 |
Why?
| | Adult | 24 | 2026 | 40449 | 0.220 |
Why?
| | Monte Carlo Method | 3 | 2026 | 155 | 0.220 |
Why?
| | Patient Reported Outcome Measures | 2 | 2026 | 488 | 0.210 |
Why?
| | Quality Improvement | 6 | 2019 | 1289 | 0.200 |
Why?
| | Hospitalization | 4 | 2020 | 2433 | 0.200 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 19 | 0.200 |
Why?
| | Adipose Tissue, Brown | 1 | 2024 | 59 | 0.200 |
Why?
| | Preoperative Care | 2 | 2016 | 379 | 0.200 |
Why?
| | Ambulatory Care Facilities | 1 | 2026 | 265 | 0.200 |
Why?
| | Renal Insufficiency | 1 | 2025 | 168 | 0.200 |
Why?
| | Task Performance and Analysis | 1 | 2024 | 198 | 0.200 |
Why?
| | Lower Extremity | 2 | 2024 | 438 | 0.190 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 156 | 0.190 |
Why?
| | Postural Balance | 1 | 2026 | 240 | 0.190 |
Why?
| | United States | 17 | 2026 | 15966 | 0.190 |
Why?
| | Surgical Procedures, Operative | 2 | 2016 | 270 | 0.190 |
Why?
| | Aged, 80 and over | 11 | 2026 | 8265 | 0.190 |
Why?
| | Group Processes | 2 | 2020 | 64 | 0.190 |
Why?
| | Artificial Limbs | 1 | 2026 | 203 | 0.190 |
Why?
| | Logistic Models | 4 | 2021 | 2117 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1325 | 0.180 |
Why?
| | Spasm | 1 | 2022 | 21 | 0.180 |
Why?
| | Cosyntropin | 1 | 2022 | 7 | 0.180 |
Why?
| | Patient Readmission | 2 | 2018 | 758 | 0.180 |
Why?
| | Weight Gain | 1 | 2026 | 556 | 0.180 |
Why?
| | Adolescent | 16 | 2024 | 22428 | 0.180 |
Why?
| | Accidental Falls | 1 | 2024 | 222 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2016 | 1030 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 457 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2026 | 365 | 0.170 |
Why?
| | Kidney Pelvis | 1 | 2021 | 21 | 0.170 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 461 | 0.170 |
Why?
| | Activities of Daily Living | 1 | 2024 | 441 | 0.170 |
Why?
| | Computer Simulation | 2 | 2026 | 1025 | 0.170 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 463 | 0.170 |
Why?
| | Palliative Care | 2 | 2026 | 1002 | 0.160 |
Why?
| | Telemedicine | 3 | 2025 | 945 | 0.160 |
Why?
| | Ureteral Obstruction | 1 | 2021 | 62 | 0.160 |
Why?
| | Disease Progression | 4 | 2022 | 2847 | 0.160 |
Why?
| | Seizures | 1 | 2024 | 460 | 0.160 |
Why?
| | Text Messaging | 1 | 2022 | 182 | 0.150 |
Why?
| | ROC Curve | 1 | 2021 | 614 | 0.150 |
Why?
| | Emergency Service, Hospital | 2 | 2026 | 2310 | 0.150 |
Why?
| | Mobile Applications | 1 | 2022 | 196 | 0.150 |
Why?
| | Resuscitation Orders | 1 | 2020 | 47 | 0.150 |
Why?
| | Inpatients | 3 | 2021 | 545 | 0.150 |
Why?
| | Postnatal Care | 1 | 2019 | 72 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 233 | 0.150 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 846 | 0.150 |
Why?
| | Epilepsy | 2 | 2024 | 376 | 0.140 |
Why?
| | Sleep | 2 | 2024 | 901 | 0.140 |
Why?
| | Prostatic Neoplasms | 1 | 2026 | 974 | 0.140 |
Why?
| | Age Factors | 6 | 2025 | 3333 | 0.140 |
Why?
| | Medical History Taking | 1 | 2019 | 117 | 0.140 |
Why?
| | Graft Survival | 1 | 2021 | 526 | 0.140 |
Why?
| | Gait | 1 | 2021 | 313 | 0.140 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5868 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2023 | 558 | 0.140 |
Why?
| | Rural Health Services | 1 | 2019 | 141 | 0.140 |
Why?
| | Hospital Costs | 1 | 2019 | 124 | 0.140 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.140 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 227 | 0.140 |
Why?
| | Child, Preschool | 10 | 2025 | 11787 | 0.140 |
Why?
| | Young Adult | 9 | 2024 | 14105 | 0.140 |
Why?
| | Automobile Driver Examination | 1 | 2017 | 9 | 0.140 |
Why?
| | Antibody Formation | 1 | 2019 | 294 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 171 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 160 | 0.130 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 136 | 0.130 |
Why?
| | Community Health Services | 1 | 2019 | 233 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1185 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2021 | 439 | 0.130 |
Why?
| | Symptom Assessment | 1 | 2019 | 137 | 0.130 |
Why?
| | Postoperative Care | 2 | 2017 | 288 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1098 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2637 | 0.130 |
Why?
| | Thoracoscopy | 1 | 2017 | 62 | 0.130 |
Why?
| | Mass Screening | 1 | 2026 | 1347 | 0.130 |
Why?
| | Thyrotropin | 1 | 2017 | 118 | 0.130 |
Why?
| | Croup | 1 | 2017 | 19 | 0.130 |
Why?
| | Automobile Driving | 2 | 2016 | 155 | 0.130 |
Why?
| | Caregivers | 1 | 2026 | 1049 | 0.130 |
Why?
| | Hydrocarbons | 1 | 2016 | 31 | 0.120 |
Why?
| | Esophagectomy | 1 | 2018 | 135 | 0.120 |
Why?
| | Transgender Persons | 1 | 2020 | 191 | 0.120 |
Why?
| | Mental Disorders | 2 | 2016 | 1168 | 0.120 |
Why?
| | Patient Participation | 1 | 2020 | 431 | 0.120 |
Why?
| | Lung | 3 | 2023 | 4109 | 0.120 |
Why?
| | Construction Industry | 1 | 2016 | 18 | 0.120 |
Why?
| | Time Factors | 5 | 2026 | 7173 | 0.120 |
Why?
| | Infant | 9 | 2024 | 10034 | 0.120 |
Why?
| | Air Pollutants, Occupational | 1 | 2016 | 42 | 0.120 |
Why?
| | Colorado | 5 | 2026 | 4564 | 0.120 |
Why?
| | Patient Discharge | 3 | 2025 | 983 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1720 | 0.120 |
Why?
| | Cross Infection | 1 | 2019 | 262 | 0.120 |
Why?
| | Quality of Life | 2 | 2026 | 3185 | 0.120 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 356 | 0.120 |
Why?
| | Hormone Replacement Therapy | 1 | 2017 | 106 | 0.120 |
Why?
| | Polysomnography | 1 | 2017 | 235 | 0.120 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 207 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 947 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 147 | 0.120 |
Why?
| | Tissue Donors | 1 | 2019 | 424 | 0.120 |
Why?
| | Body Composition | 1 | 2020 | 706 | 0.120 |
Why?
| | Medicaid | 2 | 2020 | 461 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 169 | 0.120 |
Why?
| | Organ Transplantation | 1 | 2019 | 247 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 129 | 0.120 |
Why?
| | Heart Arrest | 1 | 2020 | 407 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2020 | 456 | 0.110 |
Why?
| | Treatment Failure | 1 | 2016 | 365 | 0.110 |
Why?
| | Obesity | 2 | 2019 | 3077 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 319 | 0.110 |
Why?
| | Data Collection | 1 | 2017 | 633 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 770 | 0.110 |
Why?
| | Rehabilitation Centers | 1 | 2015 | 39 | 0.110 |
Why?
| | Risk Factors | 6 | 2019 | 10779 | 0.110 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 108 | 0.110 |
Why?
| | Life Change Events | 1 | 2015 | 147 | 0.110 |
Why?
| | Nutrition Surveys | 1 | 2016 | 282 | 0.100 |
Why?
| | Perception | 1 | 2017 | 377 | 0.100 |
Why?
| | Independent Living | 1 | 2015 | 114 | 0.100 |
Why?
| | Physician-Patient Relations | 2 | 2016 | 585 | 0.100 |
Why?
| | Accelerometry | 2 | 2025 | 119 | 0.100 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 547 | 0.100 |
Why?
| | Vaccines | 1 | 2019 | 389 | 0.100 |
Why?
| | Patient Admission | 1 | 2016 | 218 | 0.100 |
Why?
| | Poisson Distribution | 1 | 2013 | 78 | 0.100 |
Why?
| | Esophageal Neoplasms | 1 | 2018 | 347 | 0.100 |
Why?
| | Hospitals | 2 | 2016 | 730 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 430 | 0.100 |
Why?
| | Physician's Role | 1 | 2015 | 218 | 0.100 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.100 |
Why?
| | General Surgery | 1 | 2016 | 207 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2014 | 197 | 0.100 |
Why?
| | Insurance, Health | 1 | 2016 | 302 | 0.100 |
Why?
| | Cognition | 2 | 2025 | 1266 | 0.100 |
Why?
| | Nursing Homes | 1 | 2015 | 172 | 0.100 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 300 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2019 | 704 | 0.090 |
Why?
| | Occupational Exposure | 1 | 2016 | 354 | 0.090 |
Why?
| | Parents | 2 | 2021 | 1403 | 0.090 |
Why?
| | Walk Test | 2 | 2023 | 80 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2014 | 521 | 0.090 |
Why?
| | Prospective Studies | 2 | 2022 | 7990 | 0.090 |
Why?
| | Databases, Factual | 4 | 2018 | 1486 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1241 | 0.090 |
Why?
| | Cohort Studies | 5 | 2021 | 5960 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2016 | 588 | 0.080 |
Why?
| | Body Mass Index | 1 | 2020 | 2438 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2016 | 600 | 0.080 |
Why?
| | Histones | 1 | 2016 | 669 | 0.080 |
Why?
| | Single-Blind Method | 2 | 2021 | 312 | 0.080 |
Why?
| | Length of Stay | 4 | 2018 | 1337 | 0.080 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 6048 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2014 | 784 | 0.080 |
Why?
| | Recurrence | 1 | 2013 | 1135 | 0.080 |
Why?
| | Vaccination | 1 | 2019 | 1423 | 0.080 |
Why?
| | Child Abuse | 1 | 2015 | 551 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 592 | 0.080 |
Why?
| | Influenza Vaccines | 1 | 2014 | 529 | 0.070 |
Why?
| | Preventive Health Services | 2 | 2020 | 152 | 0.070 |
Why?
| | Postoperative Period | 2 | 2021 | 354 | 0.070 |
Why?
| | Guatemala | 2 | 2019 | 345 | 0.070 |
Why?
| | Sex Factors | 3 | 2020 | 2112 | 0.070 |
Why?
| | Brain Concussion | 1 | 2016 | 640 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2168 | 0.070 |
Why?
| | Comorbidity | 3 | 2017 | 1658 | 0.070 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2017 | 22 | 0.070 |
Why?
| | Minimal Clinically Important Difference | 1 | 2026 | 30 | 0.060 |
Why?
| | Morbidity | 2 | 2019 | 323 | 0.060 |
Why?
| | Mothers | 2 | 2022 | 775 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1982 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2323 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 1095 | 0.060 |
Why?
| | Survival Rate | 2 | 2020 | 2089 | 0.050 |
Why?
| | Prognosis | 2 | 2026 | 4282 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2026 | 310 | 0.050 |
Why?
| | Equivalence Trials as Topic | 1 | 2024 | 36 | 0.050 |
Why?
| | Femur | 1 | 2026 | 250 | 0.050 |
Why?
| | Pilot Projects | 2 | 2020 | 1886 | 0.050 |
Why?
| | Habits | 1 | 2024 | 52 | 0.050 |
Why?
| | Thermogenesis | 1 | 2024 | 45 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 405 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2026 | 433 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2026 | 357 | 0.050 |
Why?
| | Epilepsies, Partial | 1 | 2024 | 61 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 212 | 0.050 |
Why?
| | Wakefulness | 1 | 2024 | 169 | 0.050 |
Why?
| | Survival Analysis | 1 | 2026 | 1382 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 209 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 323 | 0.050 |
Why?
| | Language | 1 | 2025 | 321 | 0.050 |
Why?
| | Pseudomonas | 1 | 2022 | 33 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2023 | 177 | 0.050 |
Why?
| | Cotinine | 1 | 2021 | 79 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 380 | 0.040 |
Why?
| | Hydronephrosis | 1 | 2021 | 35 | 0.040 |
Why?
| | Socioeconomic Factors | 2 | 2016 | 1326 | 0.040 |
Why?
| | Pregnancy | 3 | 2019 | 7190 | 0.040 |
Why?
| | Smoking Prevention | 1 | 2021 | 166 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2020 | 1173 | 0.040 |
Why?
| | Quadriceps Muscle | 1 | 2021 | 118 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 138 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 136 | 0.040 |
Why?
| | Milk, Human | 1 | 2022 | 172 | 0.040 |
Why?
| | Urologic Surgical Procedures | 1 | 2021 | 115 | 0.040 |
Why?
| | Home Health Nursing | 1 | 2019 | 13 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2020 | 136 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 365 | 0.040 |
Why?
| | Reproductive Health | 1 | 2019 | 91 | 0.040 |
Why?
| | Health Behavior | 1 | 2024 | 785 | 0.040 |
Why?
| | Muscle Strength | 1 | 2021 | 330 | 0.040 |
Why?
| | Glucose | 1 | 2024 | 1047 | 0.040 |
Why?
| | Breast Feeding | 1 | 2022 | 448 | 0.030 |
Why?
| | Documentation | 1 | 2020 | 198 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2021 | 842 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5408 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 125 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 529 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.030 |
Why?
| | Peer Group | 1 | 2020 | 257 | 0.030 |
Why?
| | House Calls | 1 | 2019 | 154 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.030 |
Why?
| | Snoring | 1 | 2017 | 18 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 372 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 177 | 0.030 |
Why?
| | Perioperative Period | 1 | 2017 | 71 | 0.030 |
Why?
| | Women's Health | 1 | 2019 | 310 | 0.030 |
Why?
| | Mentoring | 1 | 2020 | 166 | 0.030 |
Why?
| | Cesarean Section | 1 | 2019 | 224 | 0.030 |
Why?
| | Pandemics | 1 | 2025 | 1694 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2016 | 25 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 187 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 178 | 0.030 |
Why?
| | Oximetry | 1 | 2017 | 126 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 202 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 491 | 0.030 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 340 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 4089 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 634 | 0.030 |
Why?
| | Housing for the Elderly | 1 | 2015 | 7 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 582 | 0.030 |
Why?
| | Financing, Personal | 1 | 2015 | 27 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 652 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 293 | 0.030 |
Why?
| | Health Surveys | 1 | 2017 | 518 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 219 | 0.030 |
Why?
| | Probability | 1 | 2016 | 310 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 886 | 0.030 |
Why?
| | Risk | 1 | 2017 | 911 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 147 | 0.030 |
Why?
| | Lymphocytes | 1 | 2016 | 382 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2016 | 449 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1472 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2016 | 233 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 2017 | 284 | 0.030 |
Why?
| | Rural Population | 1 | 2019 | 650 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2016 | 372 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2016 | 377 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 885 | 0.030 |
Why?
| | Health Services Research | 1 | 2016 | 396 | 0.030 |
Why?
| | Weight Loss | 1 | 2019 | 836 | 0.020 |
Why?
| | Depression | 1 | 2023 | 1558 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2016 | 335 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2015 | 539 | 0.020 |
Why?
| | Life Style | 1 | 2016 | 479 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2115 | 0.020 |
Why?
| | Body Weight | 1 | 2017 | 976 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1985 | 0.020 |
Why?
| | Disease Management | 1 | 2017 | 645 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3604 | 0.020 |
Why?
| | Oxygen | 1 | 2017 | 995 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 556 | 0.020 |
Why?
| | Surgeons | 1 | 2016 | 339 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2016 | 538 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1134 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2017 | 916 | 0.020 |
Why?
| | Registries | 1 | 2020 | 2385 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3409 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6429 | 0.020 |
Why?
|
|
Juarez-Colunga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|